- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UP-28-0037067

Monolithic India Pharmaceuticals Private Limited
About Monolithic India Pharmaceuticals Private Limited
Data last updated:
Monolithic India Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 25 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24297UP2021PTC155966.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Lokesh Kumar Jha and Prashant Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.87 Lakh, a growth of 46% compared to the previous year. For the same year it recorded a net loss of ₹86,460 (net margin -22.3%) and EBITDA of -₹84,074 (EBITDA margin -21.7%).
Monolithic India Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0037067).
Company details
Recognitions & Rankings of Monolithic India Pharmaceuticals
Contact details
Monolithic India Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressOffice No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301
- IndustryChemicals, Other Chemical Product, Manufacturing, Chemical Products Or Preparations Of A Kind Used In The Textiles
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Monolithic India Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Monolithic India Pharmaceuticals Private Limited, buy the company report.
Financials of Monolithic India Pharmaceuticals Private Limited
FY 2024 filings availableMonolithic India Pharmaceuticals Private Limited reported revenue of ₹3.87 Lakh (up 46% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 46% in the latest year. EBITDA rose 78% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹84,074 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹86,460 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -21.7% | ||
| Net Profit Margin | -22.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Monolithic India Pharmaceuticals Private Limited, buy the company report.
Board of directors of Monolithic India Pharmaceuticals Private Limited
Monolithic India Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Kumar Jha Also directs: Monolithic Parking Facilities LLP | Director | 25 Nov 2021 | 4 Years 11 Months | Current |
| Prashant Singh | Director | 25 Nov 2021 | 4 Years 11 Months | Current |
| Amish Mishra | Director | 25 Nov 2021 | 4 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Monolithic India Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Monolithic India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Monolithic India Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Monolithic India Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Amish Mishra was appointed as Director on 25 Nov 2021.
Frequently asked questions
Monolithic India Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 25 November 2021 (5+ years old) and is registered under CIN U24297UP2021PTC155966.
Monolithic India Pharmaceuticals has 3 current directors:
- Lokesh Kumar Jha - Director
- Prashant Singh - Director
- Amish Mishra - Director
The latest financial statements of Monolithic India Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Monolithic India Pharmaceuticals is U24297UP2021PTC155966. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Monolithic India Pharmaceuticals was incorporated on 25 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Amish Mishra was appointed as Director on 25 Nov 2021. Lokesh Kumar Jha was appointed as Director on 25 Nov 2021. Prashant Singh was appointed as Director on 25 Nov 2021.
Yes, Monolithic India Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0037067).
The registered office of Monolithic India Pharmaceuticals is at Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.
Monolithic India Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
Monolithic India Pharmaceuticals can be reached at its registered office: Office No. 3B Plot No. A1 3rd Floor Sector – 10 Noida, Uttar Pradesh, India – 201301.

